ES541445A0 - Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina - Google Patents

Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina

Info

Publication number
ES541445A0
ES541445A0 ES85541445A ES541445A ES541445A0 ES 541445 A0 ES541445 A0 ES 541445A0 ES 85541445 A ES85541445 A ES 85541445A ES 541445 A ES541445 A ES 541445A ES 541445 A0 ES541445 A0 ES 541445A0
Authority
ES
Spain
Prior art keywords
preparing
biopteline
eritro
hydro
sulphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES85541445A
Other languages
English (en)
Other versions
ES8607255A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanegafuchi Chemical Industry Co Ltd
Original Assignee
Kanegafuchi Chemical Industry Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanegafuchi Chemical Industry Co Ltd filed Critical Kanegafuchi Chemical Industry Co Ltd
Publication of ES541445A0 publication Critical patent/ES541445A0/es
Publication of ES8607255A1 publication Critical patent/ES8607255A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D475/00Heterocyclic compounds containing pteridine ring systems
    • C07D475/02Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES85541445A 1984-03-24 1985-03-21 Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina Expired ES8607255A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59056584A JPS60199889A (ja) 1984-03-24 1984-03-24 5,6,7,8−テトラヒドロ−l−エリスロ−ビオプテリンの硫酸塩およびその製法

Publications (2)

Publication Number Publication Date
ES541445A0 true ES541445A0 (es) 1986-05-16
ES8607255A1 ES8607255A1 (es) 1986-05-16

Family

ID=13031220

Family Applications (1)

Application Number Title Priority Date Filing Date
ES85541445A Expired ES8607255A1 (es) 1984-03-24 1985-03-21 Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina

Country Status (7)

Country Link
US (1) US4649197A (es)
EP (1) EP0156330B1 (es)
JP (1) JPS60199889A (es)
AT (1) ATE47141T1 (es)
CA (1) CA1250837A (es)
DE (1) DE3573601D1 (es)
ES (1) ES8607255A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937342A (en) * 1987-11-30 1990-06-26 Kabushiki Kaisha Vitamin Kenkyusyo Intermediates for synthesizing BH4 and its derivatives
US7442372B2 (en) 2003-08-29 2008-10-28 Biomarin Pharmaceutical Inc. Delivery of therapeutic compounds to the brain and other tissues
KR20070005550A (ko) 2003-11-17 2007-01-10 바이오마린 파머수티컬 인크. 대사 장애 치료를 위한 조성물 및 방법
WO2006055511A2 (en) 2004-11-17 2006-05-26 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
CA2588994A1 (en) * 2004-12-08 2006-06-15 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of pulmonary hypertension of the newborn
JP2009518415A (ja) * 2005-12-05 2009-05-07 バイオマリン ファーマシューティカル インコーポレイテッド 疾患の処置のための方法および組成物
US20100009997A1 (en) * 2007-01-12 2010-01-14 Biomarin Pharmaceutical Inc. Method of treating a metabolic or neuropsychiarty disorder with a bh4 derivative prodrug
CA2675134A1 (en) * 2007-01-12 2008-07-24 Biomarin Pharmaceutical Inc. Pterin analogs
WO2008128049A2 (en) 2007-04-11 2008-10-23 Biomarin Pharmaceutical Inc. Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring
AU2008347005B2 (en) 2008-01-03 2013-10-03 Biomarin Pharmaceutical Inc. Pterin analog for treating BH4 responsive condition
JP2011508781A (ja) * 2008-01-07 2011-03-17 ビオマリン プハルマセウトイカル インコーポレイテッド テトラヒドロビオプテリンの合成方法
CN102443006B (zh) 2010-10-13 2016-02-24 因华生技制药股份有限公司 (6r)-四氢生物喋呤盐酸盐的制备方法
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
WO2019175332A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4 pathway inhibition and use thereof for treating t-cell mediated autoimmune diseases or hypersensitivity
WO2019175328A1 (en) 2018-03-14 2019-09-19 Imba - Institut Für Molekulare Biotechnologie Gmbh Bh4pathwayactivationandusethereoffortreatingcancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA487930A (en) * 1952-11-11 Roth Barbara Salts of substituted pteridines and method of preparing the same
US3468886A (en) * 1967-10-23 1969-09-23 Us Health Education & Welfare Tetrahydrohomofolic acid sulfate and synthesis thereof
EP0012444B1 (de) * 1978-12-18 1984-07-25 Wachter, Helmut, Univ.-Prof. Dr. Diagnostizierverfahren, insbesondere zur Früherkennung von malignen Tumoren und/oder viralen Erkrankungen und Mittel zu seiner Durchführung
JPS5883691A (ja) * 1981-11-13 1983-05-19 Kanegafuchi Chem Ind Co Ltd 1′,2′−ジアシル−(6r,s)−5,6,7,8−テトラヒドロ−l−ビオプテリンおよびその製法
JPS60178887A (ja) * 1984-02-23 1985-09-12 Kanegafuchi Chem Ind Co Ltd 5,6,7,8−テトラヒドロ−l−ビオプテリンの製造法

Also Published As

Publication number Publication date
EP0156330B1 (en) 1989-10-11
JPH0469157B2 (es) 1992-11-05
CA1250837A (en) 1989-03-07
US4649197A (en) 1987-03-10
DE3573601D1 (en) 1989-11-16
ATE47141T1 (de) 1989-10-15
EP0156330A3 (en) 1986-10-08
EP0156330A2 (en) 1985-10-02
ES8607255A1 (es) 1986-05-16
JPS60199889A (ja) 1985-10-09

Similar Documents

Publication Publication Date Title
ES541445A0 (es) Un procedimiento para preparar un sulfato de 5,6,7,8-tetra- hidro-l-eritro-bioptelina
DE3674739D1 (de) Verfahren zur herstellung von (2,2)-paracyclophan und dessen abkoemmlinge.
MX25305A (es) Procedimiento para preparar sales de amonio de acido n5-metil-5,6,7,8-tetrahidrofolico.
ATE49969T1 (de) Verfahren zur herstellung von pteridinderivaten.
GEP19960462B (en) Process for producing calcium-salt of alpha-hydroxy-gamma-methylthio-butiric acid
JPS5219629A (en) Process for preparation of compounds containing molybdenum
GB1285610A (en) Quinacridone pigments
NO864635D0 (no) Nye krystallinske salter av aryloksyfenolaminer og deres fremstilling.
DE3461528D1 (en) Process for the preparation of n,n'-bis(2-hydroxyethyl) oxamide
DE3261468D1 (en) Process for the isolation of 2-naphthylamine-4,8-disulphonic acid
DE3560900D1 (en) Process for the preparation of salts of alkaline or earth-alkaline metals of benzaldehyde-2,4-disulfonic acid
YU109684A (en) Process for making derivatives of bicyclo-(3,2,1)-octancarboxylic acid
AR241137A2 (es) "procedimiento para preparar beta-metilen-2 o 3-tiofenetanamina".
PL121912B2 (en) Process for manufacturing 4-amino-5-chloro-1-phenylpyridaz-6-one
DE3264143D1 (en) Process for the elimination of molybdenum from aqueous solutions of manganese salts
DE3561460D1 (en) Process for the production of 1-amino-2-naphthol-4-sulphonic acid
PT85270A (en) Process for the production of vinyldiphosphonic acid and its salts
ES8505677A1 (es) Procedimiento para la preparacion del citrato de la (+) vinpocetina
FR2582651B1 (fr) Procede de preparation de vincristine
DE3560019D1 (en) Process for the production of diphenyl-4,4'-disulfonic acid
ZA869400B (en) A process for the preparation of 7alpha-acetylthiosteroids
HUT34960A (en) Process for production of 5,5-bis /2-metaxo-carbonile-amino-benzimidasole/ disulphide
IL86644A (en) Process for the production of salts of aminomalonodinitrile from malonic acid dinitrile by nitrosation, hydrogenation and precipitation with an acid
HUT45474A (en) Srocess for dechroming mother lye
PT74540B (en) Process for preparing acid addition salts of 3,4-diacyloxi-alp ha-<(methylamino)-methyl>-benzylalcohol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301